Diabetes patients likely to develop macula oedema after cataract surgery

Article

Patients with Type 2 diabetes undergoing cataract surgery are twice as likely to develop macula oedema than patients without diabetes.

Patients with Type 2 diabetes undergoing cataract surgery are twice as likely to develop macula oedema than patients without diabetes, according to Anna Wikberg-Matsson and colleagues from Uppsala University, Sweden.

A consecutive, prospective, randomized study followed two groups of patients, 40 with simplex retinopathy and 40 healthy patients, after cataract surgery. Preoperative visual acuity (VA) in the diabetes group was 0.4 and 0.5 in the control group.

At six-weeks follow-up, the VA was 0.5 and 0.8 in the diabetes and the control group, respectively whilst at six months the VA was 0.77 and 0.9, respectively. Macula oedema was seen in 77% of the diabetes patients at the six-week time point and in 30% of the controls. At six weeks, macula volume had increased in both groups but there was a significant difference between the two groups (p<0.05).

It was concluded by the researchers that patients with Type 2 diabetes are twice as likely to develop macula oedema following cataract surgery than healthy subjects.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.